Communication Strategies for Breast Cancer Risk Awareness

(MEMO Trial)

TO
Overseen ByThe Ohio State University Comprehensive Cancer Center
Age: 18 - 65
Sex: Female
Trial Phase: Academic
Sponsor: Ohio State University Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This is an online cross-sectional experimental survey study examining two cancer communication questions: 1) What features of social media messages communicating the breast cancer risks from alcohol consumption will motivate young adult women to drink less? and 2) Do message features differ in their persuasive effects based on young adult women's alcohol consumption behavior?

Who Is on the Research Team?

DM

Darren Mays, MPH, PhD

Principal Investigator

The Ohio State University Comprehensive Cancer Center

Are You a Good Fit for This Trial?

This study is for young adult women, especially those who drink alcohol. Participants should be willing to complete an online survey about their drinking habits and reactions to messages about alcohol and breast cancer risk.

Inclusion Criteria

Report drinking alcohol at least once in the past 30 days
Registered in the United States as a member of the Prolific consumer research platform
I am able and willing to complete study procedures in English.
See 2 more

Exclusion Criteria

I am younger than 18 or older than 25 years old.
I was assigned male at birth.
I am not able or willing to complete the required procedures.
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • Efficacy Message
  • Industry Deception
  • Mechanisms
  • Risk Message
  • YAW Susceptibility

Trial Overview

The trial tests different types of social media messages that talk about the link between alcohol use and breast cancer risk. It aims to see which message styles are most effective in encouraging young women to reduce drinking.

How Is the Trial Designed?

9

Treatment groups

Experimental Treatment

Group I: Arm 9: Risk and Efficacy + MechanismsExperimental Treatment3 Interventions
Group II: Arm 8: Risk and Efficacy + YAW SusceptibilityExperimental Treatment3 Interventions
Group III: Arm 7: Risk and Efficacy + Industry DeceptionExperimental Treatment3 Interventions
Group IV: Arm 6: Efficacy Only + MechanismsExperimental Treatment2 Interventions
Group V: Arm 5: Efficacy Only + YAW SusceptibilityExperimental Treatment2 Interventions
Group VI: Arm 4: Efficacy Only + Industry DeceptionExperimental Treatment2 Interventions
Group VII: Arm 3: Risk Only + MechanismsExperimental Treatment2 Interventions
Group VIII: Arm 2: Risk Only + YAW SusceptibilityExperimental Treatment2 Interventions
Group IX: Arm 1: Risk Only + Industry DeceptionExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ohio State University Comprehensive Cancer Center

Lead Sponsor

Trials
350
Recruited
295,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+